Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome

AIM: This study sought to clarify the usefulness of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC). METHODS: The subjects were 69 patients with HCC receiving lenvatinib; the median age was 73 years, and 14 and 67 patients had been previously treated with regorafenib and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchigami, Akira, Imai, Yukinori, Uchida, Yoshihito, Uchiya, Hiroshi, Fujii, Yohei, Nakazawa, Manabu, Ando, Satsuki, Sugawara, Kayoko, Nakayama, Nobuaki, Tomiya, Tomoaki, Mochida, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147769/
https://www.ncbi.nlm.nih.gov/pubmed/32275701
http://dx.doi.org/10.1371/journal.pone.0231427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147769/
https://www.ncbi.nlm.nih.gov/pubmed/32275701
http://dx.doi.org/10.1371/journal.pone.0231427

Ejemplares similares